SuperworthTenaya Therapeutics shares outstanding TNYA
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 217.6M
- On a year earlier
- +33.7%
- more shares
Tenaya Therapeutics had 217.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 33.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 175M | +103% |
| FY2024 | 86.4M | +16% |
| FY2023 | 74.4M | +35% |
| FY2022 | 55.3M | +34% |
| FY2021 | 41.3M | +3841% |
| FY2020 | 1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 217.6M | +34% | |
| Q1 FY26 | 216.9M | +97% | |
| Q4 FY25 | 175M | +103% | |
| Q3 FY25 | 163.3M | +90% | |
| Q2 FY25 | 162.8M | +90% | |
| Q1 FY25 | 109.9M | +36% | |
| Q4 FY24 | 86.4M | +16% | |
| Q3 FY24 | 86.2M | +17% | |
| Q2 FY24 | 85.7M | +17% | |
| Q1 FY24 | 81M | +11% | |
| Q4 FY23 | 74.4M | +35% | |
| Q3 FY23 | 73.9M | +79% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Tenaya Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.